| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Med Kataskeui Endymaton Esorouchon Magio Emporoviomichaniki S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.04 |
| 52 Week High | €1.23 |
| 52 Week Low | €0.83 |
| Beta | 0 |
| 1 Month Change | -10.73% |
| 3 Month Change | -10.34% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 15.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| MED | GR Luxury | GR Market | |
|---|---|---|---|
| 7D | -7.1% | 0.4% | 4.2% |
| 1Y | n/a | -4.2% | 31.5% |
Return vs Industry: Insufficient data to determine how MED performed against the Greek Luxury industry.
Return vs Market: Insufficient data to determine how MED performed against the Greek Market.
Price Volatility
| MED volatility | |
|---|---|
| MED Average Weekly Movement | 4.1% |
| Luxury Industry Average Movement | 4.4% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in GR Market | 7.8% |
| 10% least volatile stocks in GR Market | 2.4% |
Stable Share Price: MED has not had significant price volatility in the past 3 months.
Volatility Over Time: MED's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | n/a | med.com.gr |
Med Kataskeui Endymaton Esorouchon Magio Emporoviomichaniki S.A. engages in the manufacture, wholesale, and retail trade of swimwear, underwear, bathing accessories, men's and women's clothing, children's clothing, footwear, bags, towels, sunglasses, and other related products in Greece and internationally. The company was founded in 1999 and is based in Thessaloniki, Greece.
Med Kataskeui Endymaton Esorouchon Magio Emporoviomichaniki S.A. Fundamentals Summary
| MED fundamental statistics | |
|---|---|
| Market cap | €12.39m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MED income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MED perform over the long term?
See historical performance and comparison